These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
309 related items for PubMed ID: 16708588
21. Comparison of MR imaging and urodynamic findings in benign prostatic hyperplasia. Alam AM, Sugimura K, Okizuka H, Ishida J, Igawa M. Radiat Med; 2000; 18(2):123-8. PubMed ID: 10888045 [Abstract] [Full Text] [Related]
22. [Intravesical prostatic protrusion in diagnosing infravesical obstruction in men with benign prostatic hyperplasia]. Krivoborodov GG, Efremov NS, Bolotov AD. Urologiia; 2017 Jun; (2):105-109. PubMed ID: 28631916 [Abstract] [Full Text] [Related]
24. [Clinical significance of residual urine volume in bladder outlet obstruction with benign prostatic hyperplasia]. Wu Z, Wu K, Wang B. Zhonghua Wai Ke Za Zhi; 1997 Jun; 35(6):374-6. PubMed ID: 10374477 [Abstract] [Full Text] [Related]
25. Impact of different sized catheters on pressure-flow studies in patients with benign prostatic hyperplasia. Klingler HC, Madersbacher S, Schmidbauer CP. Neurourol Urodyn; 1996 Jun; 15(5):473-81. PubMed ID: 8857615 [Abstract] [Full Text] [Related]
26. Change in International Prostate Symptom Score, prostrate-specific antigen and prostate volume in patients with benign prostatic hyperplasia followed longitudinally. Tsukamoto T, Masumori N, Rahman M, Crane MM. Int J Urol; 2007 Apr; 14(4):321-4; discussion 325. PubMed ID: 17470162 [Abstract] [Full Text] [Related]
28. Do alpha1-adrenoceptor antagonists improve lower urinary tract symptoms by reducing bladder outlet resistance? Barendrecht MM, Abrams P, Schumacher H, de la Rosette JJ, Michel MC. Neurourol Urodyn; 2008 Apr; 27(3):226-30. PubMed ID: 17638312 [Abstract] [Full Text] [Related]
29. Clinical value of uroflowmentry in selected cases of bladder outlet obstruction. Lemma BE, Taye M, Hawando T, Bakke A. Ethiop Med J; 2004 Oct; 42(4):283-7. PubMed ID: 16122120 [Abstract] [Full Text] [Related]
31. Diagnostic and predictive value of voiding diary data versus prostate volume, maximal free urinary flow rate, and Abrams-Griffiths number in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia. van Venrooij GE, van Melick HH, Eckhardt MD, Boon TA. Urology; 2008 Mar; 71(3):469-74. PubMed ID: 18342189 [Abstract] [Full Text] [Related]
32. The role of uroflowmetry in diagnosis of infravesical obstruction in the patients with benign prostatic enlargement. Aganovic D. Med Arh; 2004 Mar; 58(1 Suppl 2):109-11. PubMed ID: 15137221 [Abstract] [Full Text] [Related]
36. [Quality of life assessment of the male with benign prostate hypertrophy]. Nekić VC, Tiljak H, Petricek G, Soldo D, Nekić G, Buljan N. Acta Med Croatica; 2007 Feb; 61(1):49-55. PubMed ID: 17593641 [Abstract] [Full Text] [Related]
37. [Correlation of the factors on benign prostatic hyperplasia combined with obstruction]. Chen Q, Wang YX. Zhonghua Nan Ke Xue; 2002 Feb; 8(4):299-301. PubMed ID: 12491701 [Abstract] [Full Text] [Related]
39. The value of symptom score, quality of life score, maximal urinary flow rate, residual volume and prostate size for the diagnosis of obstructive benign prostatic hyperplasia: a urodynamic analysis. van Venrooij GE, Boon TA. J Urol; 1996 Jun; 155(6):2014-8. PubMed ID: 8618311 [Abstract] [Full Text] [Related]